Recombinant Escherichia coli O7:K1 Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnE (arnE)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Escherichia coli O7:K1 ArnE Protein

The Recombinant Escherichia coli O7:K1 Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnE (arnE) is a bioengineered protein derived from the extraintestinal pathogenic E. coli strain O7:K1. This protein plays a critical role in bacterial resistance mechanisms, particularly in modifying lipopolysaccharides (LPS) to evade host immune defenses. ArnE is part of the ArnABCMTjPmrFGJKL multidrug resistance (MDR) system, which enhances resistance to antimicrobial peptides like polymyxins .

LPS Modification and Antimicrobial Resistance

ArnE facilitates the incorporation of α-L-Ara4N into LPS, a modification that reduces the net negative charge of the outer membrane. This structural change enhances resistance to cationic antimicrobial peptides (e.g., polymyxins) by preventing electrostatic interactions .

Genomic Context and Virulence

In E. coli O7:K1, arnE is part of a broader set of virulence factors shared with human extraintestinal pathogenic E. coli (ExPEC). These include:

  • Capsular polysaccharides (K1): Protect against phagocytosis and complement-mediated lysis .

  • Iron acquisition systems: Enable survival in iron-limited host environments .

  • Serum resistance genes (e.g., iss, traT): Inhibit complement activation and phagocytosis .

Regulatory Pathways

Studies in avian pathogenic E. coli (APEC) O1 strains reveal that the global regulator FNR (fumarate and nitrate reductase) modulates arnE expression indirectly. FNR regulates plasmid-encoded genes like ompT (outer membrane protease) and chuA (heme receptor), which synergize with ArnE to enhance resistance to antimicrobial peptides .

Virulence and Resistance Assays

AssayKey Findings
Antimicrobial Peptide SusceptibilityAPEC strains lacking functional arnE show reduced resistance to LL-37 and lysozyme .
Macrophage SurvivalFNR-deficient mutants exhibit impaired survival within macrophages, correlating with downregulated arnE-related pathways .

Genomic and Proteomic Insights

  • Genome Sequencing: The E. coli O7:K1 strain shares >95% similarity with human ExPEC genomes (e.g., UTI89), highlighting zoonotic potential .

  • Plasmid Content: Virulence plasmids in O7:K1 strains often encode efflux pumps (e.g., aatA) and toxin/antitoxin systems, complementing chromosomal resistance genes like arnE .

Functional Redundancy

ArnE’s role may overlap with other flippase subunits (e.g., ArnT), complicating targeted inhibition strategies.

Host Specificity

While arnE is conserved in pathogenic E. coli, its expression levels and regulatory networks vary between avian and human hosts. Further studies are needed to elucidate tissue-specific roles .

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have specific format requirements, please specify them when placing your order, and we will accommodate your request.
Lead Time
Delivery time may vary depending on the purchase method and location. For specific delivery timelines, please consult your local distributors.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance as additional charges will apply.
Notes
Repeated freezing and thawing is not recommended. For short-term storage, aliquots can be stored at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial prior to opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration between 0.1-1.0 mg/mL. We suggest adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life is influenced by factors such as storage conditions, buffer composition, temperature, and the inherent stability of the protein.
Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
arnE; ECIAI39_2405; Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnE; L-Ara4N-phosphoundecaprenol flippase subunit ArnE; Undecaprenyl phosphate-aminoarabinose flippase subunit ArnE
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-111
Protein Length
full length protein
Species
Escherichia coli O7:K1 (strain IAI39 / ExPEC)
Target Names
arnE
Target Protein Sequence
MIWLTLVFASLLSVAGQLCQKQATCFVAINKRRKHIVLWLGLALACLGLAMVLWLLVLQN VPVGIAYPMLSLNFVWVTLAAVKLWHEPVSPRHWCGVAFIIGGIVILGSTV
Uniprot No.

Target Background

Function
This protein facilitates the translocation of 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol (alpha-L-Ara4N-phosphoundecaprenol) across the inner membrane, moving it from the cytoplasmic to the periplasmic side.
Database Links
Protein Families
ArnE family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

Basic Research Questions

  • What is the functional role of ArnE protein in bacterial membranes?

    ArnE functions as a critical subunit of the 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase, which translocates alpha-L-Ara4N-phosphoundecaprenol from the cytoplasmic to the periplasmic side of the inner membrane . This translocation is essential for modifying lipopolysaccharides in the bacterial outer membrane, which contributes to antimicrobial peptide resistance. To investigate this function experimentally, researchers should consider reconstitution studies in liposomes using purified recombinant ArnE protein, followed by assays that track substrate movement across the membrane using fluorescently labeled analogs or radiolabeled substrates.

  • How should researchers optimize expression and purification of recombinant ArnE protein?

    Based on established protocols, optimal expression of ArnE requires careful consideration of several factors:

    ParameterRecommended ConditionsNotes
    Expression SystemE. coliPreferred host for membrane protein expression
    TagN-terminal His-tagFacilitates single-step affinity purification
    BufferTris/PBS-based, pH 8.0Contains 6% Trehalose for stability
    Storage-20°C/-80°C in aliquotsAvoid repeated freeze-thaw cycles
    Reconstitution0.1-1.0 mg/mL in deionized waterAdd 5-50% glycerol for long-term storage

    For membrane proteins like ArnE, detergent screening is critical during purification to maintain native conformation. Consider testing a panel of detergents including DDM, LDAO, and CHAPS at various concentrations to optimize solubilization efficiency while preserving protein activity.

  • What amino acid characteristics of ArnE are important for functional studies?

    The full-length ArnE protein from E. coli O7:K1 consists of 111 amino acids with the sequence: MIWLTLVFASLLSVAGQLCQKQATCFVAINKRRKHIVLWLGLALACLGLAMVLWLLVLQNVPVGIAYPMLSLNFVWVTLAAVKLWHEPVSPRHWCGVAFIIGGIVILGSTV . Analysis of this sequence reveals:

    • Multiple hydrophobic regions forming transmembrane domains

    • Charged residues potentially involved in substrate recognition

    • Conserved motifs across bacterial species that may be critical for function

    When designing mutagenesis studies, focus on conserved residues identified through multiple sequence alignments of ArnE proteins from E. coli, Pseudomonas aeruginosa, and Salmonella species. Alanine scanning of these conserved regions can help identify residues essential for substrate binding or membrane insertion.

  • What NIH guidelines must researchers follow when working with recombinant ArnE?

    Research involving recombinant ArnE must comply with NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules . These guidelines define recombinant nucleic acids as "molecules that a) are constructed by joining nucleic acid molecules and b) can replicate in a living cell" . Key considerations include:

    • Institutional Biosafety Committee (IBC) approval may be required before initiating experiments

    • Proper containment practices must be implemented based on risk assessment

    • Documentation and reporting requirements must be followed

    • Personnel must be adequately trained in good microbiological techniques

    For most recombinant ArnE research, experiments likely fall under Section III-D or III-E of the NIH Guidelines, requiring IBC approval before or simultaneous with initiation .

Advanced Research Questions

  • How do homologs of ArnE differ across bacterial species, and what methods best capture these differences?

    ArnE homologs have been identified in multiple Gram-negative bacteria with varying sequence conservation:

    SpeciesUniProt IDSequence LengthNotable Differences
    E. coli O7:K1B7NNT7111 aaReference sequence
    E. coli O139:H28A7ZP76111 aaIdentical length, high similarity
    Pseudomonas aeruginosa PA7A6V1N7111 aaMore divergent sequence
    Salmonella paratyphi A-PartialLimited data available
    Shigella dysenteriae Sd197-111 aaHigh similarity to E. coli

    To methodically investigate these differences, employ:

    1. Comparative genomics with phylogenetic analysis to establish evolutionary relationships

    2. Cross-species complementation assays in ArnE knockout strains to assess functional conservation

    3. Chimeric protein construction between divergent homologs to identify species-specific functional domains

    4. Heterologous expression systems to examine expression efficiency and folding differences

  • What are the most reliable experimental approaches for measuring ArnE flippase activity in vitro?

    Measuring flippase activity presents significant technical challenges due to the membrane-embedded nature of the process. A comprehensive experimental approach should include:

    1. Reconstitution System Development:

      • Purify ArnE to >90% homogeneity as confirmed by SDS-PAGE

      • Reconstitute in proteoliposomes with defined lipid composition

      • Verify correct orientation using protease protection assays

    2. Activity Measurement:

      • Develop fluorescently labeled 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol analogs

      • Establish inside-out vesicle systems to measure translocation rates

      • Implement stopped-flow spectroscopy to capture rapid kinetics

      • Utilize FRET-based assays to monitor substrate proximity to membrane leaflets

    3. Controls and Validation:

      • Include protein-free liposomes as negative controls

      • Use ATPase-dependent flippases with established assays as positive controls

      • Confirm specificity with competitive inhibition using unlabeled substrate

  • How can researchers effectively apply structural biology techniques to membrane proteins like ArnE?

    Structural characterization of membrane proteins like ArnE requires specialized approaches:

    1. Crystallization Strategies:

      • Screen detergent conditions extensively (DDM, LMNG, GDN)

      • Apply lipidic cubic phase (LCP) crystallization methods

      • Consider fusion proteins with crystallization chaperones (T4 lysozyme, BRIL)

      • Utilize nanobodies as crystallization aids, similar to those developed for CNPase

    2. Cryo-EM Alternative:

      • For challenging membrane proteins, single-particle cryo-EM may provide advantages

      • Prepare samples in nanodiscs or amphipols to maintain native environment

      • Implement focused refinement on transmembrane regions

    3. Computational Approaches:

      • Apply homology modeling if structural homologs exist

      • Use deep learning methods like those developed by Arne Elofsson's research group

      • Validate models with evolutionary coupling analysis and experimental crosslinking

  • What experimental design considerations are most important when studying ArnE in different contexts?

    When designing experiments involving ArnE, researchers should consider the balance between abstraction and detail as outlined in experimental design literature :

    1. Situational Hypotheticality:

      • Consider whether in vitro reconstituted systems adequately represent physiological conditions

      • Design experiments that bridge artificial systems and natural bacterial membranes

    2. Contextual Detail:

      • Include relevant lipid compositions that mimic bacterial inner membranes

      • Account for potential protein-protein interactions with other flippase components

    3. Actor Identity:

      • Consider strain-specific variations when choosing which ArnE homolog to study

      • Evaluate whether tagged constructs maintain native function through complementation studies

    Methodologically, researchers should implement factorial experimental designs that systematically vary these parameters to identify which factors significantly influence ArnE function.

  • How does ArnE contribute to antibiotic resistance mechanisms, and what experimental approaches best demonstrate this relationship?

    ArnE's role in antimicrobial peptide resistance can be investigated through:

    1. Genetic Approaches:

      • Generate clean deletion mutants using CRISPR-Cas9 or allelic exchange

      • Complement with wild-type and mutant versions under native promoter control

      • Create reporter strains with fluorescent proteins to monitor expression in response to antibiotics

    2. Biochemical Validation:

      • Analyze lipopolysaccharide modifications using mass spectrometry

      • Quantify 4-amino-4-deoxy-L-arabinose incorporation into lipid A

      • Measure membrane permeability with fluorescent dyes in wildtype vs. mutant strains

    3. Susceptibility Testing:

      • Determine minimum inhibitory concentrations (MICs) for polymyxins and other cationic antimicrobials

      • Perform time-kill assays at sub-MIC concentrations

      • Assess development of resistance under selective pressure

    4. In vivo Relevance:

      • Evaluate virulence in infection models with wildtype vs. arnE mutants

      • Test antibiotic efficacy in vivo against strains with varying ArnE expression levels

  • What are the best methods for studying the interplay between ArnE and other components of the lipopolysaccharide modification pathway?

    Understanding ArnE in its broader pathway context requires:

    1. Protein-Protein Interaction Studies:

      • Membrane-based bacterial two-hybrid systems

      • Co-immunoprecipitation with crosslinking for transient interactions

      • FRET pairs to monitor interactions in live bacteria

    2. Pathway Reconstitution:

      • Stepwise reconstitution of the complete pathway in liposomes

      • Development of coupled enzymatic assays to monitor sequential reactions

      • Application of surface plasmon resonance to measure binding kinetics between components

    3. Systems Biology Approaches:

      • Transcriptomic analysis to identify co-regulated genes

      • Metabolic flux analysis to measure pathway activity

      • Creation of minimal synthetic systems to define essential components

    For implementation, consider employing orthogonal approaches and validating key findings across multiple bacterial species to establish conserved mechanisms versus species-specific adaptations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.